In vitro elution of moxifloxacin and fusidic acid by a synthetic crystallic semihydrate form of calcium sulphate (Stimulan™)

International Journal of Antimicrobial Agents

Volumn 32, Issue 6, 2008, Pages 485-487

  Panagopoulos, Periklis ^a   Tsaganos, Thomas ^a   Plachouras, Diamantis ^a   Carrer, Dionyssia Pinelopi ^a   Papadopoulos, Antonios ^a   Giamarellou, Helen ^a   Kanellakopoulou, Kyriaki ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Calcium sulphate; Delivery systems; Fusidic acid; Moxifloxacin; Osteomyelitis

Indexed keywords

CALCIUM SULFATE; FUSIDIC ACID; MOXIFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BONE GRAFT; DRUG DELIVERY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; OSTEOMYELITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; AZA COMPOUNDS; BIOCOMPATIBLE MATERIALS; BONE SUBSTITUTES; CALCIUM SULFATE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; FUSIDIC ACID; QUINOLINES; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 55249091330     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.06.029     Document Type: Article

References (19)

1. Yamashita Y., Uchida A., Yamakawa T., Shinto Y., Araki N., and Kato K. Treatment of osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic. Int Orthop 22 (1998) 247-251
2. Kanellakopoulou K., and Giamarellos-Bourboulis E.J. Carrier systems for the local delivery of antibiotics in bone infection. Drugs 59 (2000) 1223-1232
3. Wichelhaus T.A., Dingeldein E., Rauschmann M., Kluge S., Dieterich R., Schafer V., et al. Elution characteristics of vancomycin, teicoplanin, gentamicin and clindamycin from calcium sulphate beads. J Antimicrob Chemother 48 (2001) 117-119
4. Kraemer H.J., Gehrke R., and Breithaupt H. Simultaneous quantification of cefotaxime, desacetylcefotaxime, ofloxacine and ciprofloxacine by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 700 (1997) 147-153
5. Wong F.A., Juzwin S.J., and Flor S.C. Rapid stereospecific high-performance chromatographic determination of levofloxacin in human plasma and urine. J Pharm Biomed Anal 15 (1997) 765-771
6. Brown N.M., Reeves D.S., and McMullin C.M. The pharmacokinetics and protein-binding of fusidic acid in patients with severe renal failure requiring either haemodialysis or continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 39 (1997) 803-809
7. Carik P.J., Dickerson L.M., and Sack J.L. Diagnosis and management of osteomyelitis. Am Fam Physician 63 (2001) 2413-2420
8. Kanellakopoulou K., Galanakis N., Giamarellos-Bourboulis E.J., Rifiotis C., Papakostas K., Andreopoulos A., et al. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin. J Antimicrob Chemother 46 (2000) 311-314
9. Dajcs J.J., Thibodeaux B.A., Marquart M.E., Girgis D.O., Traidej M., and O'Callaghan R.J. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis. Antimicrob Agents Chemother 48 (2004) 1948-1952
10. Kalteis T., Beckmann J., Schröder H.J., Handel M., Grifka J., Lehn N., et al. Moxifloxacin superior to vancomycin for treatment of bone infection-a study in rats. Acta Orthop 77 (2006) 315-319
11. Atkins B., and Gottlieb T. Fusidic acid in bone and joint infections. Int J Antimicrob Agents 12 Suppl. 2 (1999) S79-S93
12. Cerretani D., Giorgi G., Fornara P., Bocchi L., Neri L., Ceffa R., et al. The in vitro elution characteristic of vancomycin combined with imipenem-cilastatin in acrylic bone-cements: a pharmacokinetic study. J Arthroplasty 17 (2002) 619-626
13. Zalavras C.G., Patzakis M.J., and Holtom P. Local antibiotic therapy in the treatment of open fractures and osteomyelitis. Clin Orthop Relat Res 427 (2004) 86-93
14. Hariprasad S.M., Shah G.K., Chi J., and Prince R.A. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device. J Cataract Refract Surg 31 (2005) 2142-2146
15. Kleinmann G., Larson S., Neuhann I.M., Hunold A.C., LeBoyer R., Hickman S., et al. Intraocular concentrations of gatifloxacin and moxifloxacin in the anterior chamber via diffusion through the cornea using collagen shields. Cornea 25 (2006) 209-213
16. Kanellakopoulou K., Tsaganos T., Athanassiou K., Koutoukas P., Raftogiannis M., Skiadas I., et al. Comparative elution of moxifloxacin from Norian skeletal repair system and acrylic bone cement: an in vitro study. Int J Antimicrob Agents 28 (2006) 217-220
17. Bogdanovich T., Ednie L.M., Shapiro S., and Appelbaum P.C. Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother 49 (2005) 4210-4219
18. Cevher E., Orhan Z., Sensoy D., Ahiskali R., Kan P.L., Sagirli O., et al. Sodium fusidate-poly(d,l-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis. J Microencapsul 24 (2007) 577-595
19. Richelsoph K., Webb N., and Haggard W. Elution behaviour of daptomycin-loaded calcium sulphate pellets: a preliminary study. Clin Orthop Relat Res 461 (2007) 68-73